Association of TNFAIP3 With Immune-mediated TTP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Association of TNFAIP3 With Immune-mediated TTP — Stella

Home/Thrombotic Thrombocytopenic Purpura, Acquired/

View on ClinicalTrials.gov

Recruiting

Back to Thrombotic Thrombocytopenic Purpura, Acquired trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan

Key details

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Enrollment target

~400 participants

Started

April 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.